Published in Nucleic Acids Res on June 14, 2009
Prevention of Chlamydia-induced infertility by inhibition of local caspase activity. J Infect Dis (2013) 2.79
Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell (2013) 2.27
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene (2010) 1.97
Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol (2010) 1.73
Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res (2011) 1.64
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol Cancer (2010) 1.46
An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model. PLoS One (2012) 1.40
Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling. Mol Cell Biol (2010) 1.29
The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer. Cell Cycle (2010) 1.28
Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics (2011) 1.28
The miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identity. J Mammary Gland Biol Neoplasia (2012) 1.25
miRNAs and estrogen action. Trends Endocrinol Metab (2012) 1.24
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet (2013) 1.24
The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci (2012) 1.24
Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem (2012) 1.23
Estrogen receptors and human disease: an update. Arch Toxicol (2012) 1.22
MiR-155 promotes proliferation of human breast cancer MCF-7 cells through targeting tumor protein 53-induced nuclear protein 1. J Biomed Sci (2013) 1.18
Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis. J Biol Chem (2010) 1.18
The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res Treat (2010) 1.17
Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res (2012) 1.14
Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci (2011) 1.12
Regulation of breast cancer and bone metastasis by microRNAs. Dis Markers (2013) 1.12
Small molecule modifiers of the microRNA and RNA interference pathway. AAPS J (2009) 1.08
Sex differences in microRNA regulation of gene expression: no smoke, just miRs. Biol Sex Differ (2012) 1.08
RNA polymerase II binding patterns reveal genomic regions involved in microRNA gene regulation. PLoS One (2010) 1.07
MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. Biomed Res Int (2014) 1.07
Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells. BMC Cancer (2012) 1.02
Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. J Biol Chem (2010) 1.01
Derailed estrogen signaling and breast cancer: an authentic couple. Endocr Rev (2012) 1.01
Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ (2014) 1.00
Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One (2012) 1.00
Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer. Mol Biosyst (2013) 0.99
Overexpression of miR-30b in the developing mouse mammary gland causes a lactation defect and delays involution. PLoS One (2012) 0.99
RNA-induced silencing complex (RISC) Proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators. Proc Natl Acad Sci U S A (2013) 0.98
The role of S6K1 in ER-positive breast cancer. Cell Cycle (2012) 0.98
Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull (2010) 0.98
Oestrogen receptors in breast cancer: basic mechanisms and clinical implications. Ecancermedicalscience (2013) 0.97
miRNAs in breast cancer tumorigenesis (Review). Oncol Rep (2011) 0.96
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis. Cancer Cell Int (2015) 0.96
Understanding the mechanisms of human tubal ectopic pregnancies: new evidence from knockout mouse models. Hum Reprod (2009) 0.95
Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cells. Mol Endocrinol (2010) 0.95
Estrogen receptor-mediated regulation of microRNA inhibits proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2012) 0.94
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol (2015) 0.94
Identification of miR-26 as a key mediator of estrogen stimulated cell proliferation by targeting CHD1, GREB1 and KPNA2. Breast Cancer Res (2014) 0.93
A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts. Nucleic Acids Res (2012) 0.93
Steroidal regulation of uterine miRNAs is associated with modulation of the miRNA biogenesis components Exportin-5 and Dicer1. Endocrine (2010) 0.93
Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells. Cancer Lett (2011) 0.92
miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. Carcinogenesis (2012) 0.91
miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol (2012) 0.91
A MicroRNA196a2* and TP63 circuit regulated by estrogen receptor-α and ERK2 that controls breast cancer proliferation and invasiveness properties. Horm Cancer (2012) 0.90
Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer. PLoS One (2014) 0.90
miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Endocr Relat Cancer (2012) 0.90
miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas. Int J Clin Exp Pathol (2015) 0.89
Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One (2014) 0.88
Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer. Antioxid Redox Signal (2013) 0.88
Far beyond the usual biomarkers in breast cancer: a review. J Cancer (2014) 0.87
Loss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer. Cancer Res (2014) 0.86
Estrogen regulation of microRNAs, target genes, and microRNA expression associated with vitellogenesis in the zebrafish. Zebrafish (2013) 0.86
MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers? BMC Cancer (2015) 0.85
Estrogen represses gene expression through reconfiguring chromatin structures. Nucleic Acids Res (2013) 0.85
Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthma. J Allergy Clin Immunol (2015) 0.85
MiR-506 Over-Expression Inhibits Proliferation and Metastasis of Breast Cancer Cells. Med Sci Monit (2015) 0.84
An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma. J Transl Med (2012) 0.84
The many faces of estrogen signaling. Biochem Med (Zagreb) (2014) 0.84
Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology. Sci Rep (2014) 0.84
The role of non-coding RNAs in the regulation of stem cells and progenitors in the normal mammary gland and in breast tumors. Front Genet (2015) 0.83
A Sex-Specific MicroRNA-96/5-Hydroxytryptamine 1B Axis Influences Development of Pulmonary Hypertension. Am J Respir Crit Care Med (2015) 0.83
Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line. PLoS One (2012) 0.82
MicroRNA-23a participates in estrogen deficiency induced gap junction remodeling of rats by targeting GJA1. Int J Biol Sci (2015) 0.82
MicroRNA and gene networks in human diffuse large B-cell lymphoma. Oncol Lett (2014) 0.81
Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage. Mol Cell Pharmacol (2011) 0.80
Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development. Oncotarget (2015) 0.79
Celecoxib increases miR-222 while deterring aromatase-expressing breast tumor growth in mice. BMC Cancer (2014) 0.78
The onset of human ectopic pregnancy demonstrates a differential expression of miRNAs and their cognate targets in the Fallopian tube. Int J Clin Exp Pathol (2013) 0.78
Profiling of estrogen-regulated microRNAs in breast cancer cells. J Vis Exp (2014) 0.78
Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor. Mol Cell Endocrinol (2014) 0.78
Estradiol represses the G(D3) synthase gene ST8SIA1 expression in human breast cancer cells by preventing NFκB binding to ST8SIA1 promoter. PLoS One (2013) 0.78
Detection of 1α,25-dihydroxyvitamin D-regulated miRNAs in zebrafish by whole transcriptome sequencing. Zebrafish (2014) 0.78
Expression of microRNAs and isomiRs in the porcine endometrium: implications for gene regulation at the maternal-conceptus interface. BMC Genomics (2015) 0.78
E2F and microRNA regulation of angiogenesis. Am J Cardiovasc Dis (2011) 0.78
Cohort of estrogen-induced microRNAs regulate adrenomedullin expression. Am J Physiol Regul Integr Comp Physiol (2015) 0.77
Hsa-miR-375 is a predictor of local control in early stage breast cancer. Clin Epigenetics (2016) 0.77
Uterine microRNA signature and consequence of their dysregulation in uterine disorders. Anim Reprod (2010) 0.77
Prolonged ovarian hormone deprivation alters the effects of 17β-estradiol on microRNA expression in the aged female rat hypothalamus. Oncotarget (2015) 0.76
Expression Profiles of Estrogen-Regulated MicroRNAs in Breast Cancer Cells. Methods Mol Biol (2016) 0.76
MicroRNA Regulatory Networks Provide Feedback Mechanisms for Steroid Receptor Signaling. J Steroids Horm Sci (2012) 0.76
Altered of microRNA expression level in oligospermic patients. Iran J Reprod Med (2014) 0.76
Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors. Front Med (Lausanne) (2015) 0.76
An Emerging Role of micro-RNA in the Effect of the Endocrine Disruptors. Front Neurosci (2016) 0.76
Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features. Int J Oncol (2016) 0.75
miRNA clusters as therapeutic targets for hormone-resistant breast cancer. Expert Rev Endocrinol Metab (2015) 0.75
Estrogen induces RAD51C expression and localization to sites of DNA damage. Cell Cycle (2016) 0.75
MicroRNA circulating in the early aftermath of motor vehicle collision predict persistent pain development and suggest a role for microRNA in sex-specific pain differences. Mol Pain (2015) 0.75
Plasma microRNAs in ovarian cancer--response. Clin Cancer Res (2013) 0.75
Sex, epilepsy, and epigenetics. Neurobiol Dis (2014) 0.75
Expression profile of androgen-modulated microRNAs in the fetal murine lung. Biol Sex Differ (2016) 0.75
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers. Breast Cancer Res (2016) 0.75
Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy. BMC Res Notes (2017) 0.75
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
Molecular portraits of human breast tumours. Nature (2000) 94.14
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
The impact of microRNAs on protein output. Nature (2008) 32.39
RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
Switching from repression to activation: microRNAs can up-regulate translation. Science (2007) 17.00
Selective blockade of microRNA processing by Lin28. Science (2008) 14.39
Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 14.37
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell (2005) 14.32
Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell (2006) 12.73
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (2007) 12.42
Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet (2007) 10.78
miR-21-mediated tumor growth. Oncogene (2006) 9.90
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature (2008) 9.83
A custom microarray platform for analysis of microRNA gene expression. Nat Methods (2004) 9.44
The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res (2007) 9.32
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res (2008) 7.53
A microRNA signature of hypoxia. Mol Cell Biol (2006) 7.24
RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell (2007) 7.06
RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol (2006) 6.81
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol (2007) 6.41
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer (2006) 5.47
The eukaryotic genome as an RNA machine. Science (2008) 5.29
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res (2007) 5.25
Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci U S A (2007) 5.20
An E2F/miR-20a autoregulatory feedback loop. J Biol Chem (2006) 5.20
A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc Natl Acad Sci U S A (2008) 5.11
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology (2003) 4.96
Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer (2002) 4.57
The role of RNA interference in heterochromatic silencing. Nature (2004) 4.56
MicroRNA silencing through RISC recruitment of eIF6. Nature (2007) 4.37
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci (2008) 4.28
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem (2001) 3.86
Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol (2006) 3.71
The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol (2007) 3.39
REST maintains self-renewal and pluripotency of embryonic stem cells. Nature (2008) 3.06
Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res (2007) 2.95
Identification of let-7-regulated oncofetal genes. Cancer Res (2008) 2.56
Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol Cell (2006) 2.48
A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev (2007) 2.48
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res (2009) 2.43
Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Mol Cell Biol (2007) 2.14
MicroRNAs as tumor suppressors. Nat Genet (2007) 2.09
Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol (2007) 2.02
Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest (2007) 1.72
Nuclear hormone receptor regulation of microRNAs controls developmental progression. Science (2009) 1.69
MicroRNAs make big impression in disease after disease. Science (2008) 1.67
Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells. Nucleic Acids Res (2007) 1.63
Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations. Clin Cancer Res (2006) 1.38
AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer. Mol Cell Biol (2008) 1.21
The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12. Carcinogenesis (2005) 1.16
Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer. Carcinogenesis (2006) 1.03
Microarray analysis of miRNA gene expression. Methods Enzymol (2007) 0.88
Model-based analysis of ChIP-Seq (MACS). Genome Biol (2008) 51.63
Genome-wide analysis of estrogen receptor binding sites. Nat Genet (2006) 18.63
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell (2005) 14.32
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell (2008) 14.18
Model-based analysis of tiling-arrays for ChIP-chip. Proc Natl Acad Sci U S A (2006) 13.68
X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell (2006) 7.17
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell (2009) 7.09
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med (2005) 7.01
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res (2006) 6.35
miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res (2008) 6.30
Molecular determinants for the tissue specificity of SERMs. Science (2002) 6.20
Pioneer transcription factors: establishing competence for gene expression. Genes Dev (2011) 6.01
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell (2007) 5.99
Nucleosome dynamics define transcriptional enhancers. Nat Genet (2010) 5.94
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature (2012) 5.84
Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol Cell (2005) 5.38
FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet (2010) 5.22
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Formation of the androgen receptor transcription complex. Mol Cell (2002) 4.93
MicroRNAs modulate the angiogenic properties of HUVECs. Blood (2006) 4.31
Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol (2011) 4.13
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Res (2008) 4.08
NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem (2003) 3.98
A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res (2010) 3.89
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science (2012) 3.74
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55
High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell (2004) 3.46
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc Natl Acad Sci U S A (2010) 3.37
p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol (2006) 3.37
Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts. Genome Res (2008) 3.33
Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci U S A (2009) 2.95
Positive cross-regulatory loop ties GATA-3 to estrogen receptor alpha expression in breast cancer. Cancer Res (2007) 2.95
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell (2011) 2.86
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat (2009) 2.85
Differentiation-specific histone modifications reveal dynamic chromatin interactions and partners for the intestinal transcription factor CDX2. Dev Cell (2010) 2.84
Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol (2013) 2.84
Caught red-handed: Rc encodes a basic helix-loop-helix protein conditioning red pericarp in rice. Plant Cell (2006) 2.82
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev (2006) 2.76
Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery (2009) 2.64
Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell (2013) 2.56
Genetic and genomic approaches to develop rice germplasm for problem soils. Plant Mol Biol (2007) 2.53
Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature (2008) 2.51
Global dissemination of a single mutation conferring white pericarp in rice. PLoS Genet (2007) 2.45
Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep (2013) 2.37
Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer (2007) 2.30
Predicting intrinsic disorder in proteins: an overview. Cell Res (2009) 2.24
Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell (2011) 2.23
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Clin Cancer Res (2007) 2.22
MYC regulation of a "poor-prognosis" metastatic cancer cell state. Proc Natl Acad Sci U S A (2010) 2.21
Unique ERalpha cistromes control cell type-specific gene regulation. Mol Endocrinol (2008) 2.19
Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Cancer Cell (2009) 2.15
GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature (2011) 2.14
Estrogen receptor target gene: an evolving concept. Mol Endocrinol (2006) 2.09
ZNF703 is a common Luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol Med (2011) 2.07
Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev (2010) 2.06
D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer. Cancer Res (2013) 2.05
Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer. J Urol (2005) 2.01
Differential stem- and progenitor-cell trafficking by prostaglandin E2. Nature (2013) 1.99
Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J (2008) 1.96
MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst (2010) 1.94
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance. Genes Dev (2010) 1.92
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res (2011) 1.92
Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res (2009) 1.89
The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res (2009) 1.88
Alcohol alters DNA methylation patterns and inhibits neural stem cell differentiation. Alcohol Clin Exp Res (2011) 1.88
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells. Cancer Cell (2013) 1.86
Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res (2012) 1.85
CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res (2008) 1.83
Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis. Proc Natl Acad Sci U S A (2007) 1.83
SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer. J Clin Oncol (2011) 1.77
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility. Genome Res (2012) 1.77
Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium. Mol Ther (2008) 1.75
The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. Cancer Cell (2013) 1.75
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J (2011) 1.72
Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res (2002) 1.69
Optimal graph search segmentation using arc-weighted graph for simultaneous surface detection of bladder and prostate. Med Image Comput Comput Assist Interv (2009) 1.69
CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. Cancer Res (2008) 1.64
A comprehensive view of nuclear receptor cancer cistromes. Cancer Res (2011) 1.64
High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci U S A (2003) 1.60
Elucidation of the ELK1 target gene network reveals a role in the coordinate regulation of core components of the gene regulation machinery. Genome Res (2009) 1.60
Cistromics of hormone-dependent cancer. Endocr Relat Cancer (2009) 1.58
SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer (2010) 1.56
Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. Mol Endocrinol (2005) 1.55